Bridger Management LLC Lowers Holdings in Masimo Corporation $MASI

Bridger Management LLC reduced its position in Masimo Corporation (NASDAQ:MASI) by 14.4% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 33,641 shares of the medical equipment provider’s stock after selling 5,659 shares during the quarter. Masimo comprises about 3.3% of Bridger Management LLC’s holdings, making the stock its 16th largest position. Bridger Management LLC owned approximately 0.06% of Masimo worth $5,659,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in MASI. Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in shares of Masimo by 3.7% in the second quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 6,640 shares of the medical equipment provider’s stock valued at $1,117,000 after acquiring an additional 235 shares in the last quarter. SG Americas Securities LLC lifted its position in Masimo by 809.8% in the second quarter. SG Americas Securities LLC now owns 14,766 shares of the medical equipment provider’s stock valued at $2,484,000 after purchasing an additional 13,143 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Masimo by 8.8% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,562 shares of the medical equipment provider’s stock valued at $1,945,000 after purchasing an additional 939 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Masimo by 25.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,470,393 shares of the medical equipment provider’s stock worth $415,570,000 after purchasing an additional 502,555 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey raised its stake in shares of Masimo by 7.7% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 16,943 shares of the medical equipment provider’s stock worth $2,850,000 after buying an additional 1,215 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MASI. Bank of America began coverage on Masimo in a research note on Monday. They issued a “neutral” rating and a $162.00 price target on the stock. Wells Fargo & Company reduced their target price on Masimo from $190.00 to $187.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Zacks Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Finally, Piper Sandler boosted their price objective on shares of Masimo from $200.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 6th. Five research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Masimo has a consensus rating of “Hold” and a consensus price target of $188.67.

Masimo Price Performance

Shares of NASDAQ MASI opened at $147.03 on Tuesday. The company has a current ratio of 2.14, a quick ratio of 1.61 and a debt-to-equity ratio of 0.57. The company’s 50-day moving average price is $145.80 and its 200 day moving average price is $153.22. Masimo Corporation has a 52 week low of $133.70 and a 52 week high of $194.88. The stock has a market cap of $7.90 billion, a price-to-earnings ratio of -17.26 and a beta of 1.28.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. The company had revenue of $617.00 million for the quarter. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. As a group, research analysts forecast that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.